Jinru Ji

937 total citations · 1 hit paper
32 papers, 610 citations indexed

About

Jinru Ji is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Jinru Ji has authored 32 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Medicine, 14 papers in Pharmacology and 10 papers in Epidemiology. Recurrent topics in Jinru Ji's work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antibiotic Use and Resistance (7 papers). Jinru Ji is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Antibiotic Use and Resistance (7 papers). Jinru Ji collaborates with scholars based in China, United States and Belarus. Jinru Ji's co-authors include Yonghong Xiao, Beiwen Zheng, Lanjuan Li, Ping Shen, Jing Zhang, Zeqing Wei, Chaoqun Ying, Lina Zhao, Yunbo Chen and Kai Zhou and has published in prestigious journals such as Nature Communications, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jinru Ji

32 papers receiving 607 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESKAPE in China: epidemiology and characteristics of antibiotic resistance

2024 50 citations Qixia Luo, Ping Lü et al. profile →

Peers

Jinru Ji

ENDOC

PHARM

EPIDE

Deepjyoti Paul India

Alessandra Giordano Italy

Raquel Girardello Brazil

Paweł Sacha Poland

Basma Mnif Tunisia

Reem AlJindan Saudi Arabia

Jesús Machuca Spain

Roberta T. Mettus United States

Zerrin Aktaş Türkiye

Atanu Chakravarty India

Deepjyoti Paul India

Jinru Ji

455 ×1.0

184 ×1.0

ENDOC

161 ×1.2

107 ×0.8

PHARM

113 ×0.9

EPIDE

Citations per year, relative to Jinru Ji Jinru Ji (= 1×) peers Deepjyoti Paul

Countries citing papers authored by Jinru Ji

Since Specialization

Citations

This map shows the geographic impact of Jinru Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinru Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinru Ji more than expected).

Fields of papers citing papers by Jinru Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinru Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinru Ji. The network helps show where Jinru Ji may publish in the future.

Co-authorship network of co-authors of Jinru Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jinru Ji. A scholar is included among the top collaborators of Jinru Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinru Ji. Jinru Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Qixia, Ping Lu, Qian Guo, et al.. (2025). Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China. Nature Communications. 16(1). 3536–3536. 2 indexed citations

Luo, Qixia, Yuan Wang, Hao Fu, et al.. (2024). Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clinical Microbiology and Infection. 30(4). 507–514. 7 indexed citations

Hu, Juan, Yongwei Yu, Qun Su, et al.. (2024). Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients. International Journal of Antimicrobial Agents. 63(5). 107152–107152. 3 indexed citations

Wang, Xueting, Wei Yu, Chen Huang, et al.. (2023). Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation. Antibiotics. 12(2). 363–363. 1 indexed citations

Wang, Xueting, Yanzi Zhou, Xiaohui Chi, et al.. (2023). Mechanisms of ceftazidime/avibactam resistance in drug-naïve bacteraemic Enterobacterales strains without metallo-beta-lactamase production: Associated with ceftazidime impedance. International Journal of Antimicrobial Agents. 62(2). 106877–106877. 6 indexed citations

Chi, Xiaohui, Tao Chen, Yanzi Zhou, et al.. (2022). Small wards in the ICU: a favorable measure for controlling the transmission of carbapenem-resistant Klebsiella pneumoniae. Intensive Care Medicine. 48(11). 1573–1581. 19 indexed citations

Huang, Chen, et al.. (2021). Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China. Drug Design Development and Therapy. Volume 15. 2593–2603. 9 indexed citations

Shen, Chengwu, Jinru Ji, Chaoqun Ying, et al.. (2021). The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China. Frontiers in Microbiology. 12. 738812–738812. 3 indexed citations

Yu, Wei, Qixia Luo, Yunbo Chen, et al.. (2021). In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China. Frontiers in Cellular and Infection Microbiology. 11. 780365–780365. 20 indexed citations

10.

Yu, Wei, Yunbo Chen, Ping Shen, et al.. (2021). Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Pharmacology. 12. 771910–771910. 1 indexed citations

11.

Liu, Lin, Ping Shen, Beiwen Zheng, et al.. (2020). Comparative Genomic Analysis of 19 Clinical Isolates of Tigecycline-Resistant Acinetobacter baumannii. Frontiers in Microbiology. 11. 1321–1321. 10 indexed citations

12.

Huang, Chen, Beiwen Zheng, Jinru Ji, et al.. (2019). <p>Simulating moxalactam dosage for extended-spectrum β-lactamase-producing <em>Enterobacteriaceae</em> using blood antimicrobial surveillance network data</p>. Infection and Drug Resistance. Volume 12. 1199–1208. 6 indexed citations

13.

Xiao, Tingting, Kai Yang, Yanzi Zhou, et al.. (2019). Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016. Antimicrobial Resistance and Infection Control. 8(1). 144–144. 20 indexed citations

14.

Shen, Ping, Lihua Guo, Jiahua Li, et al.. (2017). Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL). Annals of Clinical Microbiology and Antimicrobials. 16(1). 37–37. 4 indexed citations

15.

Yu, Wei, et al.. (2017). Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation. Drug Design Development and Therapy. Volume 11. 1951–1956. 6 indexed citations

16.

Zheng, Beiwen, Xiawei Jiang, Hong Cheng, et al.. (2017). Genome characterization of two bile-isolated Vibrio fluvialis strains: an insight into pathogenicity and bile salt adaption. Scientific Reports. 7(1). 11827–11827. 14 indexed citations

17.

Zhang, Jing, Kai Zhou, Beiwen Zheng, et al.. (2016). High Prevalence of ESBL-Producing Klebsiella pneumoniae Causing Community-Onset Infections in China. Frontiers in Microbiology. 7. 1830–1830. 52 indexed citations

18.

Liu, Lin, Yujun Cui, Beiwen Zheng, et al.. (2016). Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach. Scientific Reports. 6(1). 26930–26930. 23 indexed citations

19.

Xiao, Yonghong, Zeqing Wei, Ping Shen, et al.. (2015). Bacterial-resistance among outpatients of county hospitals in China: significant geographic distinctions and minor differences between central cities. Microbes and Infection. 17(6). 417–425. 32 indexed citations

20.

Zhang, Jing, Beiwen Zheng, Lina Zhao, et al.. (2014). Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals. BMC Infectious Diseases. 14(1). 659–659. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact